COREY WEST: Open Payments
NPI 1720530702 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 16 payments from 7 companies in 2025. Trend: 2023 $310 · 2024 $469 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $87 |
| ABBVIE INC. | 3 | $65 |
| Astellas Pharma US Inc | 1 | $25 |
| Amgen Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 4 | $12 |
Products named: MOUNJARO, VRAYLAR, Veozah, UBRELVY, REPATHA, QULIPTA, Cologuard Collection Kit, Ozempic.
Industry payments across FL — which companies pay providers there.
